IV Nutrient Therapy: Myers Cocktail, Glutathione, NAD+ & Beyond

What Is IV Nutrient Therapy?

Intravenous (IV) nutrient therapy is the direct administration of vitamins, minerals, amino acids, antioxidants, and other therapeutic compounds into the bloodstream, bypassing the gastrointestinal tract entirely. By circumventing oral bioavailability limitations — absorption barriers, first-pass hepatic metabolism, gut inflammation, and enzymatic degradation — IV delivery achieves plasma concentrations that are physiologically and therapeutically unattainable through oral supplementation alone.

Used in integrative, functional, and naturopathic medicine for decades, IV nutrient therapy has expanded from the foundational Myers' Cocktail to a sophisticated menu of targeted protocols addressing chronic fatigue, immune dysfunction, neurological conditions, cancer support, detoxification, and cellular aging. This article provides a comprehensive clinical overview of the major IV nutrient protocols, their mechanisms, indications, dosing considerations, and integrative applications.

Why IV? The Bioavailability Argument

The central rationale for IV nutrient delivery rests on pharmacokinetics:

• Vitamin C (ascorbate): Oral dosing is capped at ~200–400 mg per dose due to saturable intestinal transporters (SVCT1/2). IV administration bypasses this ceiling entirely — 50–100 g IV produces plasma concentrations 70–100× higher than oral dosing, sufficient to generate pro-oxidant hydrogen peroxide selectively in tumor microenvironments.
• Glutathione: Oral glutathione is largely hydrolyzed in the gut to its constituent amino acids before systemic absorption. IV or liposomal delivery is required to meaningfully raise intracellular GSH levels acutely.
• NAD+: Oral NAD+ precursors (NMN, NR) raise NAD+ over days to weeks via biosynthetic pathways. IV NAD+ delivers the molecule directly to plasma, with rapid cellular uptake — producing clinical effects within hours relevant to detoxification, neurological repair, and addiction recovery.
• Magnesium: Oral magnesium is limited by intestinal tolerance and absorption efficiency. IV magnesium produces immediate smooth muscle relaxation, bronchodilation, and vasodilation — relevant in acute migraine, arrhythmia, and asthma management.

The Myers' Cocktail: Foundation of IV Nutrient Therapy

Developed by Baltimore physician John Myers, MD in the 1960s and popularized by Alan Gaby, MD through case series published in Alternative Medicine Review (2002), the Myers' Cocktail is the most widely administered IV nutrient formulation in integrative medicine.

Standard Myers' Cocktail Composition

• Magnesium chloride or sulfate: 200–800 mg
• Calcium gluconate: 200–400 mg
• Vitamin B12 (hydroxocobalamin or methylcobalamin): 1,000–5,000 mcg
• Vitamin B6 (pyridoxine): 50–100 mg
• Vitamin B5 (dexpanthenol/pantothenic acid): 100–250 mg
• Vitamin B complex (B1, B2, B3): variable
• Vitamin C (ascorbic acid): 1,000–6,000 mg
• Diluted in sterile water or normal saline, administered over 20–45 minutes

Clinical Applications of Myers' Cocktail

• Chronic fatigue syndrome (CFS/ME)
• Fibromyalgia
• Acute and chronic migraines
• Asthma and respiratory conditions
• Seasonal allergies and upper respiratory infections
• Cardiovascular disease (adjunct)
• Depression and anxiety (nutritional insufficiency component)
• Athletic performance and recovery
• General immune support and wellness optimization

Gaby's retrospective review documented consistent benefit across these conditions with a high safety profile when properly formulated and administered.

High-Dose IV Vitamin C (Ascorbate)

High-dose IV vitamin C (IVC) — typically 25–100 g per session — operates through mechanisms distinct from its antioxidant role at physiological doses. At pharmacological concentrations:

• Pro-oxidant mechanism: Ascorbate acts as a reducing agent for metal ions (Fe³⁺ → Fe²⁺), generating hydrogen peroxide (H₂O₂) via Fenton chemistry. Cancer cells, which have reduced catalase activity, cannot neutralize H₂O₂ efficiently — selectively undergoing oxidative cytotoxicity while normal cells remain protected by intact antioxidant systems.
• Collagen synthesis: Ascorbate is an essential cofactor for prolyl and lysyl hydroxylases — enzymes required for collagen crosslinking. High-dose IV-C supports connective tissue repair, wound healing, and vascular integrity.
• Immune modulation: High-dose ascorbate enhances NK cell activity, interferon synthesis, and neutrophil function while reducing cytokine storm severity in acute infections.
• Epigenetic effects: Ascorbate is a cofactor for TET enzymes mediating DNA demethylation — relevant to cancer epigenetics and immune cell differentiation.

For a complete deep-dive on IVC mechanisms and oncology protocols, see our dedicated article: Intravenous Vitamin C: A Complete Deep-Dive Guide.

IV Glutathione

Glutathione (GSH) — the body's master antioxidant — is a tripeptide (glutamate-cysteine-glycine) synthesized in virtually every cell but concentrated in the liver. It is central to phase II detoxification, heavy metal conjugation, mitochondrial protection, and immune function.

Indications for IV Glutathione

• Neurological conditions: Parkinson's disease (dopaminergic neuron protection), MS, ALS, post-COVID neurological sequelae. IV glutathione has shown benefit in Parkinson's tremor and rigidity in open-label studies (Sechi et al., 1996).
• Liver disease: Non-alcoholic fatty liver disease (NAFLD), alcoholic hepatitis, chemotherapy-induced hepatotoxicity. GSH is directly hepatoprotective, replenishing depleted liver GSH stores.
• Heavy metal detoxification: Facilitates mercury, arsenic, and lead conjugation and biliary excretion. Often combined with EDTA chelation protocols.
• Chronic fatigue and immune dysregulation: GSH depletion is documented in CFS/ME, HIV, and post-viral syndromes. IV repletion supports mitochondrial efficiency and NK cell function.
• Skin brightening: High-dose GSH inhibits tyrosinase activity, reducing melanin synthesis — a widely practiced (though regulatory-gray) application in aesthetic medicine.
• Chemotherapy adjunct: Reduces peripheral neuropathy, nephrotoxicity, and myelosuppression from cisplatin and oxaliplatin without impairing anti-tumor efficacy (multiple RCTs, including Cascinu et al.).

Dosing

Typical IV glutathione doses range from 600–2,400 mg per session, administered as a slow push or short infusion in normal saline. Frequency varies by condition — from weekly maintenance to daily induction in acute neurological or detoxification protocols. N-acetylcysteine (NAC) is frequently co-administered orally or IV to sustain cysteine availability for ongoing GSH synthesis.

IV NAD+ (Nicotinamide Adenine Dinucleotide)

NAD+ is the central coenzyme of cellular energy metabolism, mitochondrial function, DNA repair (via PARP enzymes), and sirtuin-mediated epigenetic regulation. NAD+ levels decline 40–60% between ages 20 and 60, and are further depleted by chronic inflammation, alcohol use, oxidative stress, and mitochondrial dysfunction.

Mechanisms of IV NAD+

• Mitochondrial bioenergetics: NAD+ is the terminal electron acceptor in the TCA cycle and beta-oxidation, feeding electrons into Complex I of the electron transport chain. Repleting NAD+ directly enhances ATP production capacity.
• Sirtuin activation (SIRT1–7): Sirtuins are NAD+-dependent deacetylases regulating gene expression, inflammation, circadian rhythm, and metabolic flexibility. SIRT1 activation promotes PGC-1α-driven mitochondrial biogenesis.
• PARP-mediated DNA repair: PARP1/2 consume NAD+ to repair single-strand DNA breaks. In conditions of high oxidative stress and DNA damage burden, PARP activity can deplete NAD+ — IV replenishment restores repair capacity.
• Neurological repair: NAD+ supports axonal integrity via SARM1 pathway modulation and CD38 regulation of neuroinflammation. IV NAD+ shows promise in TBI recovery, post-COVID brain fog, and neurodegenerative conditions.

Clinical Indications for IV NAD+

• Addiction recovery (alcohol, opioids, stimulants) — reduces withdrawal severity and craving intensity; used in dedicated NAD+ addiction protocols (Mestayer, Norris protocols)
• Chronic fatigue syndrome / ME-CFS
• Post-COVID long-haul syndrome
• Traumatic brain injury (TBI) and post-concussion syndrome
• Neurodegenerative disease (Parkinson's, Alzheimer's — investigational)
• Athletic performance and recovery
• Anti-aging and longevity optimization
• Depression and anxiety with mitochondrial component

Dosing & Administration

IV NAD+ is typically administered at 250–1,000 mg per session over 2–8 hours (slow infusion required to minimize side effects including chest tightness, nausea, and muscle cramping). Addiction protocols may deliver 1,000–3,000 mg/day over 10–15 consecutive days. Co-administration of oral NMN or NR between sessions sustains NAD+ elevation.

IV Phosphatidylcholine (PC)

Phosphatidylcholine is the primary phospholipid of cell membranes and a critical component of myelin sheaths, lipoproteins, and bile. IV PC therapy — using the pharmaceutical-grade formulation Plaquex — was originally developed for atherosclerosis treatment (dissolving arterial plaques) and has expanded to neurological, hepatic, and detoxification applications.

Mechanisms

• Membrane repair: Replaces oxidized, rigid phospholipids in cell membranes with functional PC — restoring membrane fluidity, receptor function, and ion channel activity.
• Myelin support: PC is a structural component of myelin. IV PC is used in MS and post-viral demyelination protocols alongside other neuroprotective agents.
• Hepatoprotection: PC stabilizes hepatocyte membranes, reduces hepatic fibrosis, and enhances bile phospholipid content — beneficial in NAFLD, alcoholic liver disease, and drug-induced hepatotoxicity.
• Lipid metabolism: PC is required for VLDL assembly and hepatic lipid export. Repleting PC improves dyslipidemia patterns in some patients.
• Heavy metal and toxin clearance: Enhanced membrane fluidity facilitates toxin mobilization and excretion; often used in combination with EDTA chelation or glutathione infusions in detoxification protocols.

Clinical Protocols

IV PC (Plaquex) is typically administered in a series of 10–40 infusions, each containing 500–2,000 mg PC in a phosphate-buffered saline solution, over 60–90 minutes. It is frequently combined with EDTA chelation, IV glutathione, or Myers' Cocktail in comprehensive integrative detoxification programs.

Additional IV Nutrient Protocols

IV Alpha-Lipoic Acid (ALA)

A universal antioxidant active in both aqueous and lipid environments, IV ALA is used for:

• Diabetic peripheral neuropathy (600–1,200 mg IV; supported by multiple European RCTs including the ALADIN and SYDNEY trials)
• Liver disease and hepatotoxicity
• Heavy metal chelation (mercury, arsenic) via its dithiol moiety
• Adjunctive cancer support (anti-proliferative and pro-apoptotic at high doses)

IV Ozone + Nutrient Combinations (UBI / MAH)

Major autohemotherapy (MAH) and ultraviolet blood irradiation (UBI) are frequently combined with IV nutrient infusions for synergistic immune activation and oxidative preconditioning. See our dedicated article: Ozone Therapy: A Complete Deep-Dive Guide.

IV Amino Acid Therapy

Targeted IV amino acid formulations address specific deficiencies or therapeutic goals:

• Taurine: Cardiac support, bile acid conjugation, neurological protection
• L-Carnitine: Mitochondrial fatty acid transport; IV use in CFS, cardiac disease, and dialysis patients
• Arginine: Nitric oxide precursor; vasodilation, endothelial function
• Lysine + Proline: Collagen synthesis support; wound healing, connective tissue repair
• Branched-chain amino acids (BCAAs): Hepatic encephalopathy, muscle wasting, catabolic illness

IV Hydrogen Peroxide (H₂O₂) — Low-Dose

Low-dose IV H₂O₂ (0.03% concentration) has been used in some integrative practices for its oxidative immune-stimulating effects. It is highly controversial, carries significant safety risks if improperly prepared, and should be distinguished from the pro-oxidant mechanism of high-dose IVC. See: Hydrogen Therapy: A Complete Deep-Dive Guide.

Safety, Monitoring & Contraindications

General Safety Profile

IV nutrient therapy has an excellent safety profile when properly prescribed, compounded, and administered. The most common adverse effects are minor and infusion-rate dependent:

• Warmth, flushing, or tingling (magnesium, niacin)
• Vein irritation or phlebitis (hypertonic solutions)
• Transient hypotension (rapid magnesium or calcium infusion)
• Nausea or chest discomfort (IV NAD+ — rate-dependent)
• Hypoglycemia (high-dose IVC stimulates insulin release in some patients)

Key Contraindications

• G6PD deficiency: Absolute contraindication for high-dose IV vitamin C. G6PD-deficient red blood cells cannot regenerate NADPH to neutralize oxidative stress — IVC can precipitate acute hemolytic anemia. G6PD testing is mandatory before IVC protocols.
• Renal insufficiency: Oxalate (a vitamin C metabolite) accumulates with compromised renal clearance. High-dose IVC should be used cautiously in renal disease with oxalate and renal function monitoring.
• Iron overload (hemochromatosis): Vitamin C enhances iron absorption and mobilization — contraindicated or requires careful monitoring in hereditary hemochromatosis.
• Congestive heart failure: Volume loading from IV infusions requires careful management in patients with fluid retention.
• Concurrent chemotherapy: Antioxidant-containing IVs (glutathione, ALA, vitamin C at lower doses) should be timed away from chemotherapy sessions to avoid potential interference with oxidative mechanisms of cytotoxic drugs.

Laboratory Monitoring

Baseline and periodic monitoring for IV nutrient protocols should include:

• G6PD enzyme activity (before IVC)
• Comprehensive metabolic panel (renal and hepatic function)
• Serum and RBC magnesium, zinc, copper
• 25(OH)D, B12, folate
• Urinary oxalate (ongoing IVC protocols)
• HbA1c and fasting glucose (IVC in diabetics)

Integrative Protocol Stacking

IV nutrient therapy achieves its greatest clinical impact when integrated with complementary modalities:

• HBOT + IVC: Sequential administration enhances tissue oxygenation and ascorbate-mediated pro-oxidant effects in oncology. See: Hyperbaric Oxygen Therapy: A Complete Deep-Dive Guide.
• Infrared sauna + IV glutathione: Sauna-induced sweating mobilizes fat-soluble toxins and heavy metals; IV GSH supports conjugation and excretion. See: Infrared Sauna Therapy: A Complete Deep-Dive Guide.
• PEMF + IV NAD+: PEMF enhances mitochondrial membrane potential and cellular uptake; IV NAD+ provides the substrate for mitochondrial bioenergetics. See: PEMF Therapy: A Complete Deep-Dive Guide.
• Ozone + IV nutrients: Ozone preconditioning upregulates Nrf2 and antioxidant enzymes; subsequent IV glutathione or ALA supports the antioxidant rebound and detoxification. See: Ozone Therapy: A Complete Deep-Dive Guide.
• PDT + IV nutrient support: Post-PDT immune priming with IV glutathione, Vitamin C, and NAD+ supports ICD amplification and tissue repair. See: Photodynamic Therapy: Root Causes, Mechanisms & Integrative Protocols.

Clinical Evidence Summary

• Myers' Cocktail: Gaby AR. "Intravenous nutrient therapy: the 'Myers' cocktail.'" Altern Med Rev. 2002;7(5):389–403.
• IV Vitamin C in cancer: Padayatty SJ et al. "Intravenously administered vitamin C as cancer therapy: three cases." CMAJ. 2006;174(7):937–942. | Welsh JL et al. Cancer Chemother Pharmacol. 2013.
• IV Glutathione in Parkinson's: Sechi G et al. "Reduced intravenous glutathione in the treatment of early Parkinson's disease." Prog Neuropsychopharmacol Biol Psychiatry. 1996;20(7):1159–1170.
• IV ALA in diabetic neuropathy: Ziegler D et al. "Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid." Diabetologia. 1995 (ALADIN trial). | Ametov AS et al. Diabetes Care. 2003 (SYDNEY trial).
• IV Glutathione as chemotherapy adjunct: Cascinu S et al. "Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer." J Clin Oncol. 1995;13(1):26–32.
• NAD+ and aging: Yoshino J et al. "NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR." Cell Metab. 2018;27(3):513–528.

Key Takeaways

• IV nutrient therapy bypasses gastrointestinal absorption limits, achieving plasma concentrations that are therapeutically transformative for specific nutrients including vitamin C, glutathione, NAD+, and magnesium.
• The Myers' Cocktail remains the foundational protocol — a broad-spectrum nutritional infusion with decades of clinical use across fatigue, migraine, immune, and cardiovascular conditions.
• High-dose IVC operates via pro-oxidant mechanisms selectively cytotoxic to cancer cells; IV glutathione is hepatoprotective and neuroprotective; IV NAD+ directly restores mitochondrial and DNA repair capacity; IV PC repairs cellular membranes and supports myelin.
• G6PD deficiency screening is mandatory before high-dose IVC. Renal function, iron status, and medication timing require careful management.
• Greatest clinical results are achieved when IV nutrient protocols are integrated with complementary modalities: HBOT, ozone, infrared sauna, PEMF, and photodynamic therapy.

Acknowledgements

This article draws on the foundational clinical work of John Myers, MD (originator of the Myers' Cocktail), Alan Gaby, MD (evidence synthesis and case series documentation), and the ongoing contributions of integrative oncology researchers at the National Institutes of Health (NIH) Office of Dietary Supplements and the Riordan Clinic, whose IVC protocol research has defined modern high-dose ascorbate practice. Citations are provided for key clinical trials and reviews referenced throughout.